These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

177 related items for PubMed ID: 19681916

  • 21. Influence of the exon 3 deletion of GH receptor and IGF-I level at diagnosis on the efficacy and safety of treatment with somatotropin in adults with GH deficiency.
    Andujar-Plata P, Fernandez-Rodriguez E, Quinteiro C, Casanueva FF, Bernabeu I.
    Pituitary; 2015 Feb; 18(1):101-7. PubMed ID: 24710993
    [Abstract] [Full Text] [Related]

  • 22. The impact of the d3-growth hormone receptor (d3-GHR) polymorphism on the therapeutic effect of growth hormone replacement in children with idiopathic growth hormone deficiency in Poland.
    Szmit-Domagalska J, Petriczko E, Drozdzynska M, Adler G, Horodnicka-Jozwa A, Ciechanowicz A, Walczak M.
    Neuro Endocrinol Lett; 2016 Sep; 37(4):282-288. PubMed ID: 27857044
    [Abstract] [Full Text] [Related]

  • 23. A polymorphism in the growth hormone receptor is associated with height in children with Prader-Willi syndrome.
    Park SW, Lee ST, Sohn YB, Kim SH, Cho SY, Ko AR, Ji ST, Kwon JY, Yeau S, Paik KH, Kim JW, Jin DK.
    Am J Med Genet A; 2011 Dec; 155A(12):2970-3. PubMed ID: 22052808
    [Abstract] [Full Text] [Related]

  • 24. Influence of the exon 3-deleted/full-length growth hormone (GH) receptor polymorphism on the response to GH replacement therapy in adults with severe GH deficiency.
    Barbosa EJ, Palming J, Glad CA, Filipsson H, Koranyi J, Bengtsson BA, Carlsson LM, Boguszewski CL, Johannsson G.
    J Clin Endocrinol Metab; 2009 Feb; 94(2):639-44. PubMed ID: 19050057
    [Abstract] [Full Text] [Related]

  • 25. Genetic predictors of long-term response to growth hormone (GH) therapy in children with GH deficiency and Turner syndrome: the influence of a SOCS2 polymorphism.
    Braz AF, Costalonga EF, Trarbach EB, Scalco RC, Malaquias AC, Guerra-Junior G, Antonini SR, Mendonca BB, Arnhold IJ, Jorge AA.
    J Clin Endocrinol Metab; 2014 Sep; 99(9):E1808-13. PubMed ID: 24905066
    [Abstract] [Full Text] [Related]

  • 26. The growth hormone receptor exon 3-deleted/full-length polymorphism and response to growth hormone therapy in prepubertal idiopathic short children.
    Hellgren G, Glad CA, Jonsson B, Johannsson G, Albertsson-Wikland K.
    Growth Horm IGF Res; 2015 Jun; 25(3):127-35. PubMed ID: 25742716
    [Abstract] [Full Text] [Related]

  • 27. The growth response to growth hormone (GH) treatment in children with isolated GH deficiency is independent of the presence of the exon 3-minus isoform of the GH receptor.
    Blum WF, Machinis K, Shavrikova EP, Keller A, Stobbe H, Pfaeffle RW, Amselem S.
    J Clin Endocrinol Metab; 2006 Oct; 91(10):4171-4. PubMed ID: 16868057
    [Abstract] [Full Text] [Related]

  • 28. Exon 3-deleted/full-length growth hormone receptor polymorphism genotype frequencies in Spanish short small-for-gestational-age (SGA) children and adolescents (n = 247) and in an adult control population (n = 289) show increased fl/fl in short SGA.
    Audí L, Esteban C, Carrascosa A, Espadero R, Pérez-Arroyo A, Arjona R, Clemente M, Wollmann H, Fryklund L, Parodi LA, Spanish SGA Study Group.
    J Clin Endocrinol Metab; 2006 Dec; 91(12):5038-43. PubMed ID: 17003087
    [Abstract] [Full Text] [Related]

  • 29. The clinical and cardiometabolic effects of d3-growth hormone receptor polymorphism in acromegaly.
    Cinar N, Dagdelen S, Yorgun H, Canpolat U, Kabakçı G, Erbas T.
    Pituitary; 2015 Feb; 18(1):116-25. PubMed ID: 24706164
    [Abstract] [Full Text] [Related]

  • 30. Association of serum components of the GH-IGFs-IGFBPs system with GHR-exon 3 polymorphism in normal and idiopathic short stature children.
    Ballerini MG, Domené HM, Scaglia P, Martínez A, Keselman A, Jasper HG, Ropelato MG.
    Growth Horm IGF Res; 2013 Dec; 23(6):229-36. PubMed ID: 23999134
    [Abstract] [Full Text] [Related]

  • 31. The d3/fl-GH receptor gene polymorphism does not influence quality of life and body composition in GH-deficient adults receiving GH replacement therapy.
    Adetunji OR, MacFarlane IA, Javadpour M, Alfirevic A, Pirmohamed M, Blair JC.
    Eur J Endocrinol; 2009 Oct; 161(4):541-6. PubMed ID: 19605543
    [Abstract] [Full Text] [Related]

  • 32. Correlation of fl/d3 polymorphism of growth hormone receptor with the first- and second-year response to recombinant human growth hormone therapy in pre-pubertal Greek children with idiopathic isolated growth hormone deficiency.
    Vassiliou G, Rousso I, Katzos G, Vavatsi-Christaki N, Tzimagiorgis G.
    J Endocrinol Invest; 2011 Sep; 34(8):609-14. PubMed ID: 20855935
    [Abstract] [Full Text] [Related]

  • 33. The exon3-deleted growth hormone receptor gene polymorphism (d3-GHR) is associated with insulin and spontaneous growth in short SGA children (NESGAS).
    Wegmann MG, Thankamony A, Roche E, Hoey H, Kirk J, Shaikh G, Ivarsson SA, Söder O, Dunger DB, Juul A, Jensen RB.
    Growth Horm IGF Res; 2017 Aug; 35():45-51. PubMed ID: 28719834
    [Abstract] [Full Text] [Related]

  • 34. The exon 3-deleted growth hormone receptor: molecular and functional characterization and impact on GH/IGF-I axis in physiological and pathological conditions.
    Filopanti M, Giavoli C, Grottoli S, Bianchi A, De Marinis L, Ghigo E, Spada A.
    J Endocrinol Invest; 2011 Dec; 34(11):861-8. PubMed ID: 22322534
    [Abstract] [Full Text] [Related]

  • 35. GH responsiveness in a large multinational cohort of SGA children with short stature (NESTEGG) is related to the exon 3 GHR polymorphism.
    Tauber M, Ester W, Auriol F, Molinas C, Fauvel J, Caliebe J, Nugent T, Fryklund L, Ranke MB, Savage MO, Clark AJ, Johnston LB, Hokken-Koelega AC, NESTEGG group.
    Clin Endocrinol (Oxf); 2007 Sep; 67(3):457-61. PubMed ID: 17555507
    [Abstract] [Full Text] [Related]

  • 36. The growth hormone receptor (GHR) exon 3 polymorphism and its correlation with metabolic profiles in obese Chinese children.
    Gao L, Zheng Z, Cao L, Shen S, Yang Y, Zhao Z, Zhi D, Cheng R, Pei Z, Yongfu Y, Luo F.
    Pediatr Diabetes; 2011 Jun; 12(4 Pt 2):429-34. PubMed ID: 21470351
    [Abstract] [Full Text] [Related]

  • 37. Growth hormone receptor (GHR) gene polymorphism and Prader-Willi syndrome.
    Butler MG, Roberts J, Hayes J, Tan X, Manzardo AM.
    Am J Med Genet A; 2013 Jul; 161A(7):1647-53. PubMed ID: 23696513
    [Abstract] [Full Text] [Related]

  • 38. GH receptor d3 polymorphism in Dutch patients with MPHD and IGHD born small or appropriate for gestational age.
    de Graaff LC, Meyer S, Els C, Hokken-Koelega AC.
    Clin Endocrinol (Oxf); 2008 Jun; 68(6):930-4. PubMed ID: 18031312
    [Abstract] [Full Text] [Related]

  • 39. Growth and Adult Height in Girls With Turner Syndrome Following IGF-1 Titrated Growth Hormone Treatment.
    Cleemann Wang A, Hagen CP, Nedaeifard L, Juul A, Jensen RB.
    J Clin Endocrinol Metab; 2020 Aug 01; 105(8):. PubMed ID: 32421787
    [Abstract] [Full Text] [Related]

  • 40. Short- and long-term responsiveness to low dose growth hormone (GH) in adult GH deficiency: Role of GH receptor polymorphism.
    Bianchi A, Giampietro A, Tartaglione L, Chiloiro S, Gentilella R, Bima C, Anile C, Olivi A, Pontecorvi A, De Marinis L.
    J Neuroendocrinol; 2019 Apr 01; 31(4):e12692. PubMed ID: 30712287
    [Abstract] [Full Text] [Related]

    Page: [Previous] [Next] [New Search]
    of 9.